• August’s top news stories

    Novo Nordisk acquired 100% of shares in UK-based biotechnology firm Ziylo under a potential deal worth more than $800m, and a new pre-clinical study at the University of Pennsylvania showed...

  • The next generation of antimalarials

    Novartis has launched a programme to add novel treatments to its malaria pipeline and to complete clinical trials for two new candidates. So why are new antimalarials needed? Abi Millar...

  • July’s top news stories

    The British Medical Association announced that the UK Government is considering stockpiling of medical supplies in case of a no-deal Brexit, and CVC Capital Partners signed an agreement to acquire...